Home All Products Tirzepatide 10 Mg Injection

Tirzepatide 10 Mg Injection

$170

Tirzepatide 10 Mg Injection is a long-acting injectable formulation developed for metabolic and endocrine management. It is a dual-acting peptide that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)Read More

Send Inquiry

View Contact Details
Contact Details
Rx Pharmaceuticals

3316 E Richert AveFresno, CA 93726, USA

+1-3176756380

rxpharmaceuticals@yahoo.com


Product Specifications

  • Dosage Strength:

    10 Mg

  • Drug Class:

    Dual GIP / GLP-1 Receptor Agonist

  • Active Ingredient:

    Tirzepatide

  • Product Category:

    Antidiabetic Medication

Description

Product Description

Tirzepatide 10 Mg Injection is a long-acting injectable formulation developed for metabolic and endocrine management. It is a dual-acting peptide that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, helping regulate blood glucose levels and metabolic function through complementary mechanisms. This advanced formulation is widely recognized in clinical settings for its role in improving glycemic control and supporting metabolic balance. By enhancing insulin secretion in a glucose-dependent manner and reducing inappropriate glucagon release, Tirzepatide helps promote more stable metabolic regulation.


Key Features



  • Dual GIP and GLP-1 receptor agonist

  • Strength: 10 mg per injection

  • Long-acting formulation for sustained activity

  • Designed for precise and consistent performance

  • Intended for clinical and professional medical use

Product Specifications
Dosage Strength 10 mg
Drug Class Dual GIP / GLP-1 receptor agonist
Active Ingredient Tirzepatide
Product Category Antidiabetic medication
Mechanism Enhances insulin secretion and glucose control
Primary Indication Type 2 diabetes
Secondary Use Weight management
Administration Route Subcutaneous injection
Frequency Once weekly
Dosage Form Injectable solution
Formulation Prefilled pen or vial
Target System Endocrine / metabolic
Molecular Type Peptide analogue
Storage Conditions Refrigerated (2–8°C)
Shelf Life 24 months
Packaging Injection pen or vial
Appearance Clear colorless solution
Manufacturer Various pharmaceutical companies
Country Of Origin Canada
Product Specifications
Dosage Strength 10 mg
Drug Class Dual GIP / GLP-1 receptor agonist
Active Ingredient Tirzepatide
Product Category Antidiabetic medication
Mechanism Enhances insulin secretion and glucose control
Primary Indication Type 2 diabetes
Secondary Use Weight management
Administration Route Subcutaneous injection
Frequency Once weekly
Dosage Form Injectable solution
Formulation Prefilled pen or vial
Target System Endocrine / metabolic
Molecular Type Peptide analogue
Storage Conditions Refrigerated (2–8°C)
Shelf Life 24 months
Packaging Injection pen or vial
Appearance Clear colorless solution
Manufacturer Various pharmaceutical companies
Country Of Origin Canada
Share
Home
All Products
Search
Contact
Need Help?

3316 E Richert AveFresno, CA 93726, USA

GET DIRECTION
Send Inquiry